SCHEMBL3780927

SCHEMBL3780927

O=C(c1ccccc1)N(C(=O)c1ccccc1)c1ccccc1.OBO

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
RAB9A P51151 2/20 0.48
TDP1 Q9NUW8 1/20 0.48
ADRA2C P18825 1/20 0.44
NR3C2 P08235 1/20 0.44
KDM4E B2RXH2 2/20 0.43
KMT2A Q03164 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CES2 O00748 2/20 0.42
CES1 P23141 2/20 0.42
ALDH1A1 P00352 2/20 0.42
DAO P14920 1/20 0.42
TSHR P16473 1/20 0.42
NAPRT Q6XQN6 1/20 0.42
LMNA P02545 1/20 0.41
HPGD P15428 3/20 0.41
MLYCD O95822 1/20 0.40
HSD11B1 P28845 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10937900 0.93 L3MBTL1 (0.53) SMN1; SMN2L3MBTL1RAB9ATDP1ADRA2C
SCHEMBL27685166 0.84 L3MBTL1 (0.50) SMN1; SMN2L3MBTL1RAB9ATDP1ADRA2C
SCHEMBL3783931 0.84 KMO (0.40) SMN1; SMN2L3MBTL1RAB9ATDP1ADRA2C
Hydrochloric Acid SCHEMBL11686024 0.83 L3MBTL1 (0.48) SMN1; SMN2L3MBTL1RAB9ATDP1ADRA2C
SCHEMBL31186281 0.82 CES2 (0.59) SMN1; SMN2L3MBTL1RAB9ATDP1CES2
SCHEMBL28075002 0.82 L3MBTL1 (0.44) SMN1; SMN2L3MBTL1RAB9ATDP1ADRA2C
SCHEMBL11686012 0.81 RAB9A (0.47) SMN1; SMN2L3MBTL1RAB9ATDP1ADRA2C
SCHEMBL729118 0.81 CES2 (0.54) SMN1; SMN2L3MBTL1RAB9ATDP1KDM4E
Benzoylphenylurea SCHEMBL83109 0.81 L3MBTL1 (0.48) SMN1; SMN2L3MBTL1RAB9ATDP1ADRA2C
SCHEMBL27258081 0.81 RAB9A (0.47) SMN1; SMN2L3MBTL1RAB9ATDP1ADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 SMN1; SMN2 4524/4885L3MBTL1 3838/4885RAB9A 1357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.